Cosmos & Space
Exploring the universe, from exoplanets and black holes to the latest missions from NASA, ESA, and beyond.
SpaceCamp Movie's Tragic Timing, 40 Years Later
Just five months after the Space Shuttle Challenger exploded on January 28, 1986, killing seven astronauts, 20th Century Fox released 'SpaceCamp,' a children's movie about a group of kids who accident
US Government Accelerates AI Federal Policy Impacts and Oversight
The Trump administration now requires leading AI developers, including Anthropic and OpenAI, to seek federal approval for each new customer using their most powerful technology.
Eli Lilly Obesity Drug Causes Widespread Gut Issues
Nearly half of the 70,000 GLP-1 drug users surveyed reported at least one side effect.
Eli Lilly invests in AI startup Absci for new hair loss treatments
Despite 71% of adolescents with severe alopecia achieving successful hair regrowth with its existing drug, Eli Lilly is now betting on an early-stage AI startup for hair loss treatments.
Judge Blocks Restrictions on SNAP Dollars Buying Candy
In a significant blow to state-level efforts to control food choices, a federal judge in Washington, D.
Echo map hints at dark matter clusters by supermassive black holes
In five of 14 observed galaxies, a new 'echo mapping' technique has revealed mass around supermassive black holes increases in a way visible matter alone cannot explain, strongly hinting at dense dark
Maternity deserts worsen Black maternal health crisis
From 2016 to 2020, Black women in Harris County faced the nation's highest pregnancy-related death rate: 83.
Medicaid fraud playbook hits disability care, risks patient access
In Minnesota, around 3,400 home disability and mental health care providers abruptly lost Medicaid funding.
AI System SA-FARI Reveals Individual Animal Lives From Footage
An international team, including researchers from the University of Bristol , has developed an AI system called SA-FARI.
Macron Hosts Global Dialogue on Economic Cooperation
While French President Emmanuel Macron hosted a video call where China's vice premier advocated for inclusive global economic cooperation, an outgoing Israeli minister simultaneously discussed a speci
Total solar eclipse reveals rare sunset spectacle over Europe
From Spain's east coast, eclipse chasers will witness a totally eclipsed sun just a couple of degrees above the western horizon, minutes from sunset—a rare celestial alignment.
Sanofi diabetes drug Tzield now approved for children
The U.S. Food and Drug Administration has approved Sanofi's Tzield injection for children aged 8 and above with newly diagnosed stage 3 type 1 diabetes. This marks the first opportunity to slow the lo
Hospitals Cut Costs with Integrated Care
UVM Medical Center loses $460,000 daily, forcing 142 job cuts.
Pope Leo XIV's Encyclical Warns AI Needs Disarming, Global Action
Pope Leo XIV's inaugural 83-page encyclical, 'Magnifica Humanitas', warns that unchecked artificial intelligence risks becoming a modern Tower of Babel that needs to be 'disarmed'.
Researchers find 14-protein blood test predicting lung cancer risk
In a groundbreaking re-analysis, an existing anti-inflammatory drug nearly halved lung cancer risk in individuals identified by a specific 14-protein blood signature.
Mallorca offers prime viewing for 2026 total solar eclipse
While millions plan to witness the 2026 total solar eclipse from Spain, only a sliver of coastline, like Mallorca's Playa de Palma, will offer the truly breathtaking sight: the sun just 2.
Boehringer Ingelheim drug slashes liver and belly fat
In Phase 3 trials, Boehringer Ingelheim's experimental obesity drug, survodutide, helped recipients shed up to 17% of their body weight over 76 weeks, crucially preserving muscle mass.
Medicare offers $50 monthly GLP-1 access amid obesity drug competition
Starting July 1, 2026, eligible Medicare beneficiaries will pay just $50 a month for certain GLP-1 obesity drugs.
Lilly's oral obesity drug shows promising safety and tolerability
Lilly's experimental oral obesity drug, aleniglipron, helped patients lose up to 12.
Retatrutide's Triple Hormone Action Aims to Revolutionize Obesity Treatment
Patients on the highest dose of retatrutide lost an average of 28% of their body weight over 80 weeks in the latest study, a result mirroring bariatric surgery, according to the South Florida Reporter
Africa CDC, WHO Launch $518M Ebola Plan in Central Africa
An ongoing Ebola outbreak, fueled by the Bundibugyo virus, has already claimed 63 lives and infected approximately 400 people.
HHS Authorizes Experimental Ebola Therapy for High-Risk Exposures
The U.S. Department of Health and Human Services (HHS) has authorized an experimental monoclonal antibody treatment, MBP-134, for Americans facing high-risk Ebola exposures. This move sidesteps tradit
Alnylam partners with Inceptive Nucleics for AI-driven RNAi therapeutics
Alnylam Pharmaceuticals, a leader in RNAi therapeutics, just committed $30 million upfront and up to $2 billion to Silicon Valley biotech startup Inceptive Nucleics.
Medicare Unveils $50 Monthly Cap on Obesity Drugs
Starting in July, eligible Medicare beneficiaries will access GLP-1 weight-loss medications for a monthly cost of just $50, according to The Motley Fool .
Turkey's Hair Transplant Industry 'Hacks' Global Market
A hair transplant procedure costing up to $30,000 in the U.S. can be secured for as little as $3,000 in Turkey, often including travel and accommodation. This price disparity has made Turkey the global leader in hair restoration, effectively 'hacking' the global industry.
Revolution Medicines' Experimental Pancreatic Cancer Drug Shows Promise
Revolution Medicines' experimental drug daraxonrasib doubled the median overall survival for patients with metastatic pancreatic cancer to 13.2 months in its pivotal Phase 3 trial.
BioNTech, Pfizer Share Bispecifics Data at ASCO
BioNTech's BNT142 achieved 7 RECIST 1.
Bristol Myers Squibb shows strong multiple myeloma data
In a significant development for multiple myeloma patients, Bristol Myers Squibb's mezigdomide triplet demonstrated a median progression-free survival of 18 months, more than doubling the 8.
Bepirovirsen data shows functional cure in 19% of hepatitis B patients
An experimental hepatitis B treatment achieved a 'functional cure' in nearly 1 in 5 patients during its pivotal Phase 3 studies, a significant stride against a chronic viral infection that afflicts mi
New drug Bepirovirsen functionally cures hepatitis B in some patients
In two late-stage clinical trials, GSK's experimental drug Bepirovirsen achieved a functional cure for 19% of patients with chronic hepatitis B, a disease that has long resisted effective treatment.